ArticleHuman vaccines & immunotherapeutics2022
Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Coverage and determinants of childhood immunization in Somalia: A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2026Pooled it
- COVID-19 vaccine hesitancy in Ethiopia: a scoping review for equitable vaccine access.Frontiers in health services · 2025Pooled it
- Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.Human vaccines & immunotherapeutics · 2024Pooled it
- COVID-19 vaccination intention among nursing, medical, and dental students: A systematic review and meta-regression analysis.Human vaccines & immunotherapeutics · 2023Pooled it
- Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.Human vaccines & immunotherapeutics · 2023Trial
- Integrated surveillance in Kilifi reveals continued SARS-CoV-2 circulation and immune escape of emerging JN.1 sublineages post-pandemic.Frontiers in cellular and infection microbiology · 2026Article
- Strategies to promote COVID-19 vaccination in Northern Ghana: a qualitative study of stakeholders' perspectives.BMC public health · 2025Article
- Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.Virology · 2025Article
- A cross-sectional survey of COVID-19 testing status among vaccine recipients in Gombe State, North-Eastern Nigeria.BMC public health · 2025Article
- COVID-19 vaccination implementation in six lower- and middle-income countries: Successes, challenges, and lessons for pandemic preparedness.PLOS global public health · 2025Article
- Factors affecting equitable access and uptake of COVID-19 vaccines in Ghana: a scoping review.Frontiers in public health · 2025Article
- Immunization status and its determinants among children aged 12-23 months at community health centers in Mogadishu, Somalia: a cross-sectional study.Frontiers in pediatrics · 2025Article
- Healthcare-seeking behavior among people with HIV undergoing TB screening during the COVID-19 pandemic.IJTLD open · 2024Article
- Lingering challenges in malaria elimination efforts in sub-Saharan Africa: Insights and potential solutions.Health science reports · 2024Article
- Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.PLOS digital health · 2024Article
- Strengthening the WHO Regional Office for Africa (WHO AFRO) COVID-19 vaccination information system.BMJ global health · 2024Article
- COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: A repeated cross-sectional study.PLOS global public health · 2024Article
- Community Health Volunteers' experiences of implementing COVID-19 vaccine education and promotion in Kenya: a qualitative descriptive study.Frontiers in public health · 2024Article
- Health care workers hospitalized for COVID-19 in Liberia: who were they, and what were their outcomes?F1000Research · 2024Article
- Determinants of COVID-19 Vaccine Uptake Among Health Workers and General Public in Tanzania.The East African health research journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in global healthcare. While more than half of the population of the developed countries have been fully vaccinated, only a small percentage of the African population has received one vaccine dose so far, a far cry from the global vaccination targets. Furthermore, several low and middle income (LMICs) African countries lack the competence, infrastructure, logistics, and financial resources to mass-vaccinate their populations. This paper highlights the causes and implications of the low COVID-19 vaccine coverage on Africa and the global community, and discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.